HOME >> BIOLOGY >> NEWS
Open Access Initiative from Oxford Journals

Oxford University Press (OUP) is initiating an Open Access experiment with one of its flagship journals, Nucleic Acids Research (NAR), recently listed by ISI as one of the top ten 'hottest' journals of the decade in biology and biochemistry . This initiative is in response to calls from the academic community to make research freely available online without the barrier of a subscription to access.

NAR will adopt an author-funded publishing model for a key section of the journal (the annual Database Issue published in January 2004), with these papers being freely available online from the moment they are published. If successful, the rest of the journal would gradually move to an open access model over a transitional period of 4-5 years, at which point all research published in NAR would be funded in such a way.

"As a University Press we believe in making research as globally accessible as possible", commented Martin Richardson, Director of OUP Journals Division, "but very few well-established journals have made a move to Open Access. NAR is a highly respected international journal, and as such we must ensure that its quality is maintained through continuing to cover the costs that the refereeing process and online publishing incur. Our proposal is to cover these costs through a combination of author charges and subscription revenues, with author charges gradually increasing over time until the model is self-funding. We believe that the adoption of a transitional approach is of vital importance for both authors and readers. Unless funding conventions change, and all authors have access to sufficient financial resources to pay for the full publication costs of their research, it is unlikely that Open Access publishing would be widely adopted by well-established journals."

OUP hopes that its initiative will help lead the way in exploring alternatives to the subscription model that will make research literature as widely accessible as possib
'"/>

Contact: Rachel Goode
rachel.goode@oupjournals.org
44-795-749-1505
Oxford University Press
7-Aug-2003


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. Access to DNA secrets yields better understanding of genes, possible tool for disease diagnosis
3. Open Access journals proven to compete on quality
4. OUP launch a new Open Access Journal on Complementary and Alternative Medicine
5. BioMed Central explodes Open Access myths
6. Access to healthy foods limited in poor neighborhoods
7. Sick Kids Improves Access To Global Genome Database
8. Keck Futures Initiative announces grant recipients
9. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
10. Hydrogen Initiative report from American Physical Society panel released
11. Initiative launched for computer science

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... ... July 08, 2019 , ... On June ... ownership of the innovation behind two Danisco amylase patent applications (EP2859097 and EP2825643). ... based on prior art was without merit and awarded costs to Danisco. ...
(Date:6/20/2019)... Fla. (PRWEB) , ... June 19, 2019 , ... ... recently announced by the Infectious Diseases Society of America Foundation, and the possibly ... on Aging to study infectious agents in AD, are a “welcome affirmation” of ...
(Date:6/14/2019)... ... ... Molecular diagnostics segment is the fastest-growing segment within the global IVD market. The ... are expected to drive the growth are infectious diseases, cancer, and transplant diagnostics. ... The World Molecular Diagnostics Market, 8th Edition . , The discovery of the structure ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... PARK, Md. (PRWEB) , ... July 15, 2019 , ... ... DNA so that a certain trait can be removed, replaced, or edited, but Yiping ... is looking far beyond these traditional applications in his latest publication in Nature Plants. ...
(Date:7/17/2019)... (PRWEB) , ... July 16, ... ... a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene ... Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space ...
(Date:7/17/2019)... ... 2019 , ... Quidel is the market leader in point-of-care ... and Siemens Healthineers and Response Biomedical also are among the top companies. The ... (POC) Diagnostics . , Quidel is a market leader in rapid immunoassays and ...
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las Vegas ... Heroes Program. The Veterans included individuals and families from all over the US, with ... military Veteran, teacher or first responder to receive a regenerative therapy at a training ...
Breaking Biology Technology:
Cached News: